• 1
    Schrecker AW, Hartwell JL. Communications-components of podophyllin. XX. The absolute configuration of podophyllotoxin and related lignans. J Org Chem 1956; 21: 3812.
  • 2
    Hande KR. Etoposide: four decades of development of a topoisomerase II inhibitor. Eur J Cancer 1998; 34: 151421.
  • 3
    Zhao Y, Wang CN, Wu ZH, Fang JH, Zhu L. Synthesis and antitumor activity of novel aroylthiourea derivatives of podophyllotoxin. Invest New Drugs 2012; 30: 1724.
  • 4
    Choi HJ, Fukui M, Zhu BT. Role of cyclin B1/Cdc2 up-regulation in the development of mitotic prometaphase arrest in human breast cancer cells treated with nocodazole. PLoS ONE 2011; 6: 113.
  • 5
    Dai XJ, Yamasaki KS, Yang LJ et al. Keratinocyte G2/M growth arrest by 1,25-dihydroxyvitamin D3 Is caused by Cdc2 phosphorylation through Wee1 and Myt1 regulation. J Invest Dermatol 2004; 122: 135664.
  • 6
    Yu LJ, Orlandi L, Wang P et al. UCN-01 abrogates G2 arrest through a Cdc2-dependent pathway that is associated with inactivation of the Wee1 Hu kinase and activation of the Cdc25C phosphatase. J Biol Chem 1998; 273: 3345564.
  • 7
    Tanabe K, Ikegami Y, Ishida R, Andoh T. Inhibition of topoisomerase II by antitumor agents bis (2,6-dioxopiperazine) derivatives. Cancer Res 1991; 51: 49037.
  • 8
    Gordaliza M, Garcia PA, Corral JM, Castro MA, Gomez-Zurita MA. Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives. Toxicon 2004; 44: 44159.
  • 9
    Corellou F, Brownlee C, Kloareg B, Bouget F. Cell cycle-dependent control of polarised development by a cyclin-dependent kinase-like protein in the Fucus zygote. Development 2001; 128: 438392.
  • 10
    Moon DO, Kim MO, Nam TJ, Kim SK, Choi YH, Kim GY. Pectenotoxin-2 induces G2/M phase cell cycle arrest in human breast cancer cells via ATM and Chk1/2-mediated phosphorylation of cdc25C. Oncol Rep 2010; 24: 2716.
  • 11
    Lu XB, Nguyen TA, Donehower LA. Reversal of the ATM/ATR- mediated DNA damage response by the oncogenic phosphatase PPM1D. Cell Cycle 2005; 4: 10604.
  • 12
    Tyagi A, Singh RP, Agarwal C, Siriwardana S, Sclafani RA, Agarwal R. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR–Chk1/2– Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells. Carcinogenesis 2005; 26: 197887.
  • 13
    Park I, Avraham HK. Cell cycle-dependent DNA damage signaling induced by ICRF-193 involves ATM, ATR, CHK2, and BRCA1, Exp. Cell Res 2006; 312: 19962008.